Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Mesoporous silica nanoparticle pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body.

Lee SB, Kim HL, Jeong HJ, Lim ST, Sohn MH, Kim DW.

Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10549-52. doi: 10.1002/anie.201304026. Epub 2013 Aug 16.

PMID:
23956036
2.

Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.

Miller L, Winter G, Baur B, Witulla B, Solbach C, Reske S, Lindén M.

Nanoscale. 2014 May 7;6(9):4928-35. doi: 10.1039/c3nr06800e.

PMID:
24675844
3.

In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.

Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2014 Nov 3;11(11):4007-14. doi: 10.1021/mp500306k. Epub 2014 Jun 25.

4.

Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging.

Shi S, Chen F, Cai W.

Nanomedicine (Lond). 2013 Dec;8(12):2027-39. doi: 10.2217/nnm.13.177. Review.

5.

One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).

Wängler C, Waser B, Alke A, Iovkova L, Buchholz HG, Niedermoser S, Jurkschat K, Fottner C, Bartenstein P, Schirrmacher R, Reubi JC, Wester HJ, Wängler B.

Bioconjug Chem. 2010 Dec 15;21(12):2289-96. doi: 10.1021/bc100316c. Epub 2010 Nov 17.

PMID:
21082773
6.

18F-labeled proteins.

Wu Z, Kandeel F.

Curr Pharm Biotechnol. 2010 Sep 1;11(6):572-80. Review.

PMID:
20497120
7.

Labeling strategies with F-18 for positron emission tomography imaging.

Gu Y, Huang D, Liu Z, Huang J, Zeng W.

Med Chem. 2011 Sep;7(5):334-44. Review.

PMID:
21711224
8.

Synthesis of ligand-functionalized water-soluble [18F]YF3 nanoparticles for PET imaging.

Xiong L, Shen B, Behera D, Gambhir SS, Chin FT, Rao J.

Nanoscale. 2013 Apr 21;5(8):3253-6. doi: 10.1039/c3nr00335c. Epub 2013 Mar 19.

10.

Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging.

Denk C, Svatunek D, Filip T, Wanek T, Lumpi D, Fröhlich J, Kuntner C, Mikula H.

Angew Chem Int Ed Engl. 2014 Sep 1;53(36):9655-9. doi: 10.1002/anie.201404277. Epub 2014 Jul 2.

PMID:
24989029
11.

Radiosyntheses using fluorine-18: the art and science of late stage fluorination.

Cole EL, Stewart MN, Littich R, Hoareau R, Scott PJ.

Curr Top Med Chem. 2014;14(7):875-900. Review.

12.

Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node.

Sun Y, Yu M, Liang S, Zhang Y, Li C, Mou T, Yang W, Zhang X, Li B, Huang C, Li F.

Biomaterials. 2011 Apr;32(11):2999-3007. doi: 10.1016/j.biomaterials.2011.01.011. Epub 2011 Feb 3.

PMID:
21295345
13.

The next generation of positron emission tomography radiopharmaceuticals in oncology.

Rice SL, Roney CA, Daumar P, Lewis JS.

Semin Nucl Med. 2011 Jul;41(4):265-82. doi: 10.1053/j.semnuclmed.2011.02.002. Review.

14.

Recent trends in bioorthogonal click-radiolabeling reactions using fluorine-18.

Pretze M, Pietzsch D, Mamat C.

Molecules. 2013 Jul 22;18(7):8618-65. doi: 10.3390/molecules18078618. Review.

15.

Visible-light-excited and europium-emissive nanoparticles for highly-luminescent bioimaging in vivo.

Wu Y, Shi M, Zhao L, Feng W, Li F, Huang C.

Biomaterials. 2014 Jul;35(22):5830-9. doi: 10.1016/j.biomaterials.2014.03.080. Epub 2014 Apr 17.

PMID:
24746969
16.

18F labeled nanoparticles for in vivo PET-CT imaging.

Devaraj NK, Keliher EJ, Thurber GM, Nahrendorf M, Weissleder R.

Bioconjug Chem. 2009 Feb;20(2):397-401. doi: 10.1021/bc8004649.

17.

Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosis.

Lee S, Kang SW, Ryu JH, Na JH, Lee DE, Han SJ, Kang CM, Choe YS, Lee KC, Leary JF, Choi K, Lee KH, Kim K.

Bioconjug Chem. 2014 Mar 19;25(3):601-10. doi: 10.1021/bc500020g. Epub 2014 Feb 19.

18.

The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration.

Lee CM, Jeong HJ, Kim DW, Sohn MH, Lim ST.

Nanotechnology. 2012 May 25;23(20):205102. doi: 10.1088/0957-4484/23/20/205102. Epub 2012 Apr 30.

PMID:
22543822
19.

Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging.

Dunphy MP, Zanzonico P, Veach D, Somwar R, Pillarsetty N, Lewis J, Larson S.

Mol Imaging Biol. 2012 Feb;14(1):25-31. doi: 10.1007/s11307-010-0462-2.

20.

Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.

Lee JE, Lee N, Kim T, Kim J, Hyeon T.

Acc Chem Res. 2011 Oct 18;44(10):893-902. doi: 10.1021/ar2000259. Epub 2011 Aug 17. Review.

PMID:
21848274
Items per page

Supplemental Content

Write to the Help Desk